SCHEMBL25633777

SCHEMBL25633777

CCC(C)C(C)C1OC(=O)C(C)C1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14428823 0.83 HIF1A (0.33) —
SCHEMBL25633775 0.80 — —
SCHEMBL20126411 0.80 — —
SCHEMBL25633774 0.77 — —
SCHEMBL10110534 0.74 MEN1 (0.31) —
SCHEMBL12833579 0.71 HIF1A (0.34) —
SCHEMBL20009694 0.71 HIF1A (0.39) —
SCHEMBL13120133 0.69 HIF1A (0.35) —
SCHEMBL13105443 0.69 HIF1A (0.35) —
SCHEMBL17973347 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230181523-A1 GLUCONIC ACID DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF MICROBIAL INFECTIONS GEDEA BIOTECH AB (SE) 2023-06-15 — — US disclosed
Send feedback